Selena Simmons-Duffin

The Trump administration did not respond to my request for comment by airtime.

President Trump has been pretty understated on abortion this term, and anti-abortion advocates have noticed and called for him to be more forceful.

Here's Mary Ziegler.

She's an expert in the legal history of abortion at UC Davis.

She says this decision is going to send shockwaves through medicine, through politics.

And we're just at the beginning.

You're welcome.

Louisiana has an abortion ban.

They argued that FDA allowing Mifepristone through the mail undermined their ban.

A district court judge put the case on hold in April.

Louisiana appealed that decision to the Fifth Circuit Court of Appeals, and a panel of judges on that court agreed with the state, which means that telemedicine access to Mifepristone has just ended for the whole country, effective immediately.

The case was brought by the state of Louisiana against the Food and Drug Administration.

Their argument centered around the FDA's decision to remove an in-person requirement for patients receiving mifepristone, one of the medications used for abortion and miscarriage management.

A district court judge put the case on hold in April, but a panel on the Fifth Circuit Court of Appeals agreed with Louisiana.

The Fifth Circuit ruling ends telemedicine mifepristone access for the whole country, effective immediately.

The drug makers are expected to appeal to the Supreme Court.

Doctors say mifepristone is safe, that the in-person requirement is medically unnecessary, and that it makes it harder for women to access abortion.

Selena Simmons-Duffin, NPR News, Washington.

The One Big Beautiful Bill Act passed by Republicans in Congress last summer created a federal work requirement for Medicaid.

Adults up to age 64 will have to regularly prove that they are working or that they qualify for an exemption.